Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.3K
Overview
44.3K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

770
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
770

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surveillance of catheter-associated urinary tract infections at an Australian tertiary hospital, 2024-2025.

Infection, disease & health·2026
Same author

Effectiveness of oral care for the prevention of non-ventilator hospital-acquired pneumonia (HAPPEN): a multicentre, stepped-wedge, cluster-randomised trial in Australia.

The Lancet. Infectious diseases·2026
Same author

Menstruation is associated with cyclical granulysin peaks in vaginal secretions despite stable expression by cervicovaginal immune cells.

bioRxiv : the preprint server for biology·2026
Same author

Projected public health benefits of a hypothetical HSV-1 vaccine in the United States: A mathematical modeling analysis.

Science advances·2026
Same author

Room-return ventilation and N95 respirator policies for reducing airborne pathogen exposure on hospital wards.

The Journal of hospital infection·2026
Same author

Evolving global sexually transmitted infection guidance: translating evidence-based WHO recommendations into clinical practice.

Sexually transmitted infections·2026

Related Experiment Video

Updated: Jun 21, 2025

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

6.5K

Vaccine value profile for herpes simplex virus.

Christine Johnston1, Suzanne Scheele2, Laura Bachmann3

  • 1Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA.

Vaccine
|July 13, 2024
PubMed
Summary

Developing vaccines for herpes simplex virus (HSV-1 and HSV-2) is crucial for reducing global disease burden. A vaccine value profile (VVP) assesses the public health, economic, and societal impact of potential HSV vaccines.

Keywords:
Herpes simplex virusVaccine

More Related Videos

Plaquing of Herpes Simplex Viruses
04:41

Plaquing of Herpes Simplex Viruses

Published on: November 5, 2021

5.6K
Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins
08:26

Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins

Published on: August 31, 2017

13.7K

Related Experiment Videos

Last Updated: Jun 21, 2025

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

6.5K
Plaquing of Herpes Simplex Viruses
04:41

Plaquing of Herpes Simplex Viruses

Published on: November 5, 2021

5.6K
Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins
08:26

Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins

Published on: August 31, 2017

13.7K

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are widespread chronic infections causing significant global morbidity.
  • HSV-2 is a primary cause of genital ulcer disease and increases HIV acquisition risk.
  • Both HSV types cause neonatal herpes and neurological conditions, necessitating effective control.

Purpose of the Study:

  • To discuss the vaccine value profile (VVP) for HSV-1 and HSV-2.
  • To provide a holistic assessment of available data on potential HSV vaccines.
  • To inform the public health, economic, and societal value of pipeline HSV vaccines.

Main Methods:

  • The study discusses the vaccine value profile (VVP) for HSV.
  • The VVP was developed by subject matter experts from diverse organizations.
  • Assessment utilized existing and publicly available information.

Main Results:

  • Vaccination is identified as the most efficient strategy to mitigate the global impact of HSV infections.
  • Prophylactic vaccines aim to prevent infection in susceptible individuals, while therapeutic vaccines target those with symptomatic genital HSV-2.
  • The VVP aims to identify current research and knowledge gaps in HSV vaccine development.

Conclusions:

  • A comprehensive VVP is essential for evaluating the potential impact of HSV vaccines.
  • Addressing knowledge gaps through VVP is critical for advancing vaccine development and implementation.
  • The development of effective HSV vaccines holds significant promise for reducing disease burden worldwide.